Pharmaceutical Companies in New York City, New York

99 pharmaceutical companies in New York City, New York, United States, compiled from public registers and the BioBridgeX marketplace. Open any company for its headquarters, FDA-registered sites and public filings.

Pharmaceutical Companies in New York City, New York

99 companies, best-documented first.

Show the first companies

1. Immune Response BioPharma, Inc.New York City, New York, United States
2. Cambrian BioPharma IncNew York City, New York, United States
3. Reset Pharmaceuticals, Inc.New York City, New York, United States
4. TheraBiogen, Inc.New York City, New York, United States
5. Vector Therapeutics, Inc.New York City, New York, United States
6. Accustem Sciences Inc.OTC: ACUTNew York City, New York, United States
7. Research Alliance Corp IIINasdaq: RACCNew York City, New York, United States
8. Revium Rx.OTC: RVRCNew York City, New York, United States
9. Siga Technologies IncNasdaq: SIGANew York City, New York, United States
10. TrialSpark, Inc.New York City, New York, United States
11. Aceto Management, L.L.C.New York City, New York, United States
12. Attune Pharmaceuticals, Inc.New York City, New York, United States
13. Companion Spine, LLCNew York City, New York, United States
14. Gilgamesh Pharma Inc.New York City, New York, United States
15. Meves Pharmaceuticals, Inc.New York City, New York, United States
16. Somnum Pharma, Inc.New York City, New York, United States
17. Voltron Therapeutics, Inc.New York City, New York, United States
18. Nexentis Technologies Inc.Nasdaq: NXTSNew York City, New York, United States
19. Phosplatin Therapeutics Inc.New York City, New York, United States
20. Vitalis Therapeutics, Inc.New York City, New York, United States

Other life science companies in New York City, New York

Outsourcing a study or a manufacturing run?

Describe the work once and compare quotes from CROs and CDMOs on BioBridgeX. Free for buyers.

Counts include published company profiles only and update daily. Data licences

Is a company missing or wrong? Tell us.